Production (Stage)
NuGen Medical Devices Inc.
NGMDF
$0.043
$0.042942,900.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.41M | -3.85M | -6.11M | -5.64M | -6.73M |
| Total Depreciation and Amortization | 453.60K | 471.60K | 470.80K | 489.90K | 506.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.76M | 178.70K | 1.68M | 1.28M | 1.53M |
| Change in Net Operating Assets | -661.50K | -205.80K | 1.63M | 1.52M | 624.50K |
| Cash from Operations | -3.38M | -3.41M | -2.33M | -2.36M | -4.07M |
| Capital Expenditure | -7.40K | -7.40K | -2.20K | -2.20K | -2.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -900.00 | -1.20K | -1.20K | -38.20K | -37.90K |
| Cash from Investing | -8.30K | -8.60K | -3.40K | -40.40K | -40.10K |
| Total Debt Issued | 0.00 | 0.00 | 10.00M | -- | -- |
| Total Debt Repaid | -7.00K | -27.80K | -17.80K | -48.30K | -860.10K |
| Issuance of Common Stock | 10.53M | 11.24M | 870.00K | 2.16M | 6.34M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 7.71M | 8.22M | 7.96M | 1.57M | 4.08M |
| Foreign Exchange rate Adjustments | -- | -- | -- | 32.00K | -3.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.32M | 4.80M | 5.63M | -796.40K | -31.40K |